Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data

被引：0
|
作者：
Hamedi, Zahra
Lo, Andrea Yachee
Berkman, Jonathan David
Alesi, Erin R.
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Div Hematol Oncol & Palliat Care, Massey Comprehens Canc Ctr, Richmond, VA USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6022
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis
    Hsiang-Fong Kao
    Huai-Cheng Huang
    Bin-Chi Liao
    Ruey-Long Hong
    BMC Cancer, 22
  • [2] Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    BMC CANCER, 2022, 22 (01)
  • [3] Real-world outcomes and costs in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Lafuma, A.
    Cotte, F-E.
    Le Tourneau, C.
    Emery, C.
    Gaudin, A-F.
    Torreton, E.
    Gourmelen, J.
    Bonastre, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma
    Zhang, Ximei
    Wang, Peiguo
    Chai, Yanlan
    Zhou, Xuan
    Li, Ping
    Wang, Xudong
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (01)
  • [5] Survival in patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab or cetuximab-based therapy: A realworlddata study with the TriNetX platform
    Ugidos De La Varga, L.
    Ruiz del Arbol, N.
    Hernandez-Ibarburu, G.
    Delia, E.
    Peinado, P.
    Torres Velasco, M.
    Alvarez Gallego, R.
    Sanchez-Miguel, C. G. Munoz
    Garcia Morillo, M.
    Toledano, C.
    Cubillo, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S587 - S587
  • [6] Real-world data of nivolumab efficacy for treatment of recurrent or metastatic head and neck squamous cell carcinoma
    Nosova, M. V.
    Stativko, O.
    Tsareva, E.
    Shangina, I.
    Ibragimova, M.
    Zueva, E.
    Latkin, V.
    Sobolev, M.
    Kuchevskaya, O.
    Arapova, O.
    Sabitov, E.
    Antonova, T.
    Pokataev, I.
    Galkin, V. N.
    ANNALS OF ONCOLOGY, 2024, 35
  • [7] Role of c-MET pathway in the outcome prediction of cetuximab-based therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Casado, Victoria
    Luis Arranz, Juan
    Zazo, Sandra
    Martin Valades, Jose Ignacio
    Madoz, Juan
    Domine, Manuel
    Perez-Gonzalez, Nuria
    Lobo, Francisco
    Rincon, Raul
    Rubio, Gustavo
    Canadas, Carmen
    Leon, Ana
    Izarzugaza, Yann
    Campos, Angel
    Serrano, Gloria
    Carames, Cristina
    Rojo, Federico
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database
    Lu, Hsueh-Ju
    Hsieh, Meng-Che
    Wang, Hung-Ming
    Hsieh, Jason Chia-Hsun
    Yen, Chia-Jui
    Wu, Shang-Yin
    Huang, Huai-Cheng
    Wang, Hui-Ching
    Chu, Pen-Yuan
    Chen, Tien-Hua
    Chien, Chih-Yen
    Huang, Tai-Lin
    Chang, Yi-Fang
    Hua, Chun-Hung
    Lien, Ming-Yu
    Chen, Jo-Pai
    Lu, Wei-Chen
    Lin, Jin-Ching
    Wang, Chen-Chi
    Liu, Yi-Chun
    Yang, Muh-Hwa
    Lou, Pei-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1063 - 1073
  • [9] Importance of c-MET pathway as a predictor of cetuximab-based therapy outcome in head and neck recurrent or metastatic squamous cell carcinoma
    Zazo, S.
    Chamizo, C.
    Perez-Gonzalez, N.
    Auz, C. L.
    Daoud, L.
    Medina, C.
    Gavin, E.
    Carvajal, N.
    Madoz, J.
    Garcia-Foncillas, J.
    Rojo, F.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 318 - 318
  • [10] REAL-WORLD USE OF PEMBROLIZUMAB COMBINATION REGIMENS IN FIRST-LINE RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Black, Christopher
    Wang, Liya
    Ramakrishnan, Karthik
    Goto, Daisuke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A832 - A832
12345